Dyne Therapeutics (DYN) Competitors

Dyne Therapeutics (NASDAQ:DYN) and Janux Therapeutics (NASDAQ:JANX) are both mid-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, earnings, community ranking, profitability, valuation, institutional ownership and risk.

Is DYN or JANX more profitable?

Dyne Therapeutics has a net margin of 0.00% compared to Janux Therapeutics' net margin of -721.18%. Janux Therapeutics' return on equity of -17.88% beat Dyne Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dyne Therapeutics	N/A	-136.35%	-103.67%
Janux Therapeutics	-721.18%	-17.88%	-15.95%

Does the media favor DYN or JANX?

In the previous week, Janux Therapeutics had 11 more articles in the media than Dyne Therapeutics. MarketBeat recorded 13 mentions for Janux Therapeutics and 2 mentions for Dyne Therapeutics. Dyne Therapeutics' average media sentiment score of 1.93 beat Janux Therapeutics' score of 0.52 indicating that Dyne Therapeutics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Dyne Therapeutics	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Janux Therapeutics	5 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community believe in DYN or JANX?

Janux Therapeutics received 9 more outperform votes than Dyne Therapeutics when rated by MarketBeat users. However, 64.71% of users gave Dyne Therapeutics an outperform vote while only 58.82% of users gave Janux Therapeutics an outperform vote.

Company	Underperform	Outperform
Dyne Therapeutics	Outperform Votes 11 64.71%	Underperform Votes 6 35.29%
Janux Therapeutics	Outperform Votes 20 58.82%	Underperform Votes 14 41.18%

Do institutionals and insiders hold more shares of DYN or JANX?

96.7% of Dyne Therapeutics shares are held by institutional investors. Comparatively, 75.4% of Janux Therapeutics shares are held by institutional investors. 20.8% of Dyne Therapeutics shares are held by insiders. Comparatively, 35.4% of Janux Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Which has more volatility & risk, DYN or JANX?

Dyne Therapeutics has a beta of 0.95, meaning that its stock price is 5% less volatile than the S&P 500. Comparatively, Janux Therapeutics has a beta of 4.18, meaning that its stock price is 318% more volatile than the S&P 500.

Do analysts recommend DYN or JANX?

Dyne Therapeutics currently has a consensus price target of $37.43, suggesting a potential upside of 58.26%. Janux Therapeutics has a consensus price target of $61.33, suggesting a potential upside of 25.55%. Given Dyne Therapeutics' stronger consensus rating and higher probable upside, research analysts plainly believe Dyne Therapeutics is more favorable than Janux Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dyne Therapeutics	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	3.14
Janux Therapeutics	0 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has stronger valuation & earnings, DYN or JANX?

Janux Therapeutics has higher revenue and earnings than Dyne Therapeutics. Janux Therapeutics is trading at a lower price-to-earnings ratio than Dyne Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dyne Therapeutics	N/A	N/A	-$235.94M	-$3.94	-6.00
Janux Therapeutics	$8.08M	312.21	-$58.29M	-$1.34	-36.46

Summary

Janux Therapeutics beats Dyne Therapeutics on 10 of the 18 factors compared between the two stocks.